TP53 and prostate cancer: For these studies, we obtained a novel murine PTEN−/− p53−/− prostate cancer cell line (P3CA) developed by Dr. Ming Chen (Duke University) that was derived from a genetic mouse prostate cancer model syngeneic on C57BL/6.